日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Avacopan is effective in inducing remission for MPA/GPA, regardless of changes in serum C5a levels: a single-center study in Japan.

Avacopan 可有效诱导 MPA/GPA 缓解,而与血清 C5a 水平的变化无关:日本的一项单中心研究

Ushio Yusuke, Shimada Hiromi, Wakiya Risa, Nakashima Shusaku, Miyagi Taichi, Sugihara Koichi, Mino Rina, Mizusaki Mao, Chujo Kanako, Manabe Naoto, Kadowaki Norimitsu, Dobashi Hiroaki

Clinical characteristics and quality of life of patients with Behcet's disease with arthritis in Japan

日本患有白塞氏病伴关节炎患者的临床特征和生活质量

Sugihara, Koichi; Wakiya, Risa; Kameda, Tomohiro; Shimada, Hiromi; Nakashima, Shusaku; Miyagi, Taichi; Ushio, Yusuke; Mino, Rina; Mizusaki, Mao; Chujo, Kanako; Kagawa, Ryoko; Yamaguchi, Hayamasa; Manabe, Naoto; Kadowaki, Norimitsu; Dobashi, Hiroaki

Nintedanib combined with immunosuppressive agents improves forced vital capacity in connective tissue disease-associated PF-ILD: a single-center study

尼达尼布联合免疫抑制剂可改善结缔组织病相关肺纤维化间质性肺病患者的用力肺活量:一项单中心研究

Ushio, Yusuke; Wakiya, Risa; Kameda, Tomohiro; Nakashima, Shusaku; Shimada, Hiromi; Miyagi, Taichi; Sugihara, Koichi; Mino, Rina; Mizusaki, Mao; Chujo, Kanako; Kagawa, Ryoko; Yamaguchi, Hayamasa; Kadowaki, Norimitsu; Dobashi, Hiroaki

Pregnancy course and outcomes of patients with polymyositis and dermatomyositis (PM/DM) managed in a single center

单中心管理的多发性肌炎和皮肌炎(PM/DM)患者的妊娠过程和结局

Mino, Rina; Shimada, Hiromi; Wakiya, Risa; Nakashima, Shusaku; Miyagi, Taichi; Sugihara, Koichi; Ushio, Yusuke; Mizusaki, Mao; Chujo, Kanako; Kameda, Tomohiro; Kanenishi, Kenji; Kadowaki, Norimitsu; Dobashi, Hiroaki

Preterm birth is strongly affected by the glucocorticoid dose during pregnancy in women complicated by systemic lupus erythematosus

系统性红斑狼疮患者妊娠期间糖皮质激素剂量对早产有显著影响。

Shimada, Hiromi; Wakiya, Risa; Kanenishi, Kenji; Miyatake, Nobuyuki; Nakashima, Shusaku; Mansour, Mai Mahmoud Fahmy; Kato, Mikiya; Miyagi, Taichi; Sugihara, Koichi; Ushio, Yusuke; Mino, Rina; Mizusaki, Mao; Kameda, Tomohiro; Kadowaki, Norimitsu; Dobashi, Hiroaki

FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis

FDG-PET/CT成像参数用于预测类风湿性关节炎患者甲氨蝶呤相关淋巴增生性疾病的自发性消退

Kameda, Tomohiro; Nakashima, Shusaku; Mitamura, Katsuya; Yamamoto, Yuka; Norikane, Takashi; Shimada, Hiromi; Wakiya, Risa; Kato, Mikiya; Miyagi, Taichi; Sugihara, Koichi; Mino, Rina; Mizusaki, Mao; Kadowaki, Norimitsu; Dobashi, Hiroaki

Systemic lupus erythematosus with various clinical manifestations in a patient with hereditary angioedema: a case report

一例伴有遗传性血管性水肿的系统性红斑狼疮患者,表现出多种临床症状:病例报告

Ushio, Yusuke; Wakiya, Risa; Kameda, Tomohiro; Nakashima, Shusaku; Shimada, Hiromi; Mansour, Mai Mahmoud Fahmy; Kato, Mikiya; Miyagi, Taichi; Sugihara, Koichi; Mino, Rina; Mizusaki, Mao; Ibuki, Emi; Kadowaki, Norimitsu; Dobashi, Hiroaki

Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy

接受免疫抑制治疗的风湿病患者对BNT162b2 mRNA COVID-19疫苗的免疫原性

Sugihara, Koichi; Wakiya, Risa; Shimada, Hiromi; Kameda, Tomohiro; Nakashima, Shusaku; Kato, Mikiya; Miyagi, Taichi; Mizusaki, Mao; Mino, Rina; Nomura, Yumi; Inoo, Masayuki; Kadowaki, Norimitsu; Dobashi, Hiroaki

Factors affecting the Apgar score of offsprings born to mothers suffering from systemic lupus erythematosus

影响患有系统性红斑狼疮的母亲所生婴儿Apgar评分的因素

Shimada, Hiromi; Kameda, Tomohiro; Kanenishi, Kenji; Miyatake, Nobuyuki; Nakashima, Shusaku; Wakiya, Risa; Kato, Mikiya; Miyagi, Taichi; Mansour, Mai Mahmoud Fahmry; Hata, Toshiyuki; Kadowaki, Norimitsu; Dobashi, Hiroaki

Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose

羟氯喹治疗系统性红斑狼疮患者的疗效和安全性取决于给药剂量

Wakiya, Risa; Kameda, Tomohiro; Nakashima, Shusaku; Shimada, Hiromi; Fahmy Mansour, Mai Mahmoud; Kato, Mikiya; Miyagi, Taichi; Kadowaki, Norimitsu; Dobashi, Hiroaki